Cargando…

Heterogeneous multimodal biomarkers analysis for Alzheimer’s disease via Bayesian network

By 2050, it is estimated that the number of worldwide Alzheimer’s disease (AD) patients will quadruple from the current number of 36 million, while no proven disease-modifying treatments are available. At present, the underlying disease mechanisms remain under investigation, and recent studies sugge...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yan, Su, Yi, Zhou, Xiao-Hua, Huang, Shuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992017/
https://www.ncbi.nlm.nih.gov/pubmed/27610127
http://dx.doi.org/10.1186/s13637-016-0046-9